References
- Aguiar MMG, Rodrigues JM, Cunha AS. Encapsulation of insulin-cyclodextrin complex in PLGA microspheres: A new approach for prolonged pulmonary insulin delivery. J Microencapsulation 2004; 21: 553–564
- Alexander C, Shakesheff KM. Responsive polymers at the biology/materials science interface. Adv Mater 2006; 18: 3321–3328
- Bender ML, Killheffer JV. Chymotrypsins. Crit Rev Biochem 1973; 1: 149–199
- Bilati U, Allemann E, Doelker E. Poly(D,L-lactide-co-glycolide) protein-loaded nanoparticles prepared by the double emulsion method—processing and formulation issues for enhanced entrapment efficiency. J Microencapsulation 2005; 22: 205–214
- Breitenbach A, Li YX, Kissel T. Branched biodegradable polyesters for parenteral drug delivery systems. J Control Rel 2000; 64: 167–178
- Brock FM, Forsberg CW, Buchanan-Smith JG. Proteolytic activity of rumen microorganisms and effects of proteinase inhibitors. Appl Environ Microbiol 1982; 44: 561–569
- Castellanos IJ, Cruz G, Crespo R, Griebenow K. Encapsulation-induced aggregation and loss in activity of γ-chymotrypsin and their prevention. J Control Rel 2002; 81: 307–319
- Charney J, Tomarelli RM. A colorimetric method for the determination of the proteolytic activity of duodenal juice. J Biol Chem 1947; 171: 501–505
- Crotts G, Park TG. Preparation of porous and nonporous biodegradable polymeric hollow microspheres. J Control Rel 1995; 35: 91–105
- Davis SS, Illum L, Stolnik S. Polymers in drug delivery. Curr Opin Colloid Interface Sci 1996; 1: 660–666
- De Jesús OLP, Ihre HR, Gagne L, Fréchet JMJ, Szoka FC. Polyester dendritic systems for drug delivery applications: In vitro and in vivo evaluation. Bioconj Chem 2002; 13: 453–461
- Dinarvand R, Moghadam SH, Sheikhi A, Atyabi F. Effect of surfactant HLB and different formulation variables on the properties of poly-D,L-lactide microspheres of naltrexone prepared by double emulsion technique. J Microencapsulation 2005; 22: 139–151
- Gabel D. Active site titration of immobilized chymotrypsin with a fluorogenic reagent. FEBS Lett 1974; 49: 280–281
- Gaspar MM, Blanco D, Cruz MEM, Alonso MJ. Formulation of L-asparaginase-loaded poly(lactide-co-glycolide) nanoparticles: Influence of polymer properties on enzyme loading, activity and in vitro release. J Control Rel 1998; 52: 53–62
- Graves RA, Moiseyev R, Freeman T, Mandal TK. Effect of surfactant on the characteristics of biodegradable microcapsules. J Biomater Sci, Polym Ed 2005; 16: 585–596
- Guiziou B, Armstrong DJ, Elliott PNC, Ford JL, Rostron C. Investigation of in-vitro release characteristics of NSAID-loaded polylactic acid microspheres. J Microencapsulation 1996; 13: 701–708
- Gupta MN, Roy I. Freeze-drying pf proteins: Some emerging concerns. Biotechnol Appl Biochemy 2004; 39: 165–177
- Huibers PDT, Lobanov VS, Katritzky AR, Shah DO, Karelson M. Prediction of critical micelle concentration using quantitative structure-property relationship approach. J Colloid Interface Sci 1997; 187: 113–120
- Jalil R, Nixon JR. Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: Problems associated with preparative techniques and release properties. J Microencapsulation 1990; 7: 297–325
- Jiang G, Woo BH, Kang F, Singh J, DeLuca PP. Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(D,L-lactide-co-glycolide)microspheres. J Control Rel 2002; 79: 137–145
- Juni K, Ogata J, Nakano M, Ichihara T, Mori K, Akagi M. Preparation and evaluation in vitro and in vivo of polylactic acid microspheres containing doxorubicin. Chem Pharm Bull 1985; 33: 313–318
- Kallinteri P, Higgins S, Hutcheon G, St. Pourcain CC, Garnett M. Novel functionalized biodegradable polymers for nanoparticle drug delivery systems. Biomacromolecules 2005; 6: 1885–1894
- Kim BK, Hwang SJ, Park JB, Park HJ. Characteristics of felopine-located poly(ε-caprolactone) microspheres. J Microencapsulation 2005; 22: 193–203
- Le Ray A-M, Chiffoleau S, Looss P, Grimandi G, Gouyette A, Daculsi G, Merle C. Vancomycin encapsulation in biodegradable poly(e-caprolactone) microparticles for bone implantation. Biomaterials 2003; 24: 443–449
- Obeidat WM, Price JC. Viscosity of polymer solution phase and other factors controlling the dissolution of theophylline microspheres prepared by the emulsion solvent evaporation method. J Microencapsulation 2003; 20: 57–65
- Ogawa Y, Yamamoto M, Okada H, Yashiki T, Shimamoto T. A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or co-poly (lactic/glycolic) acid. Chem Pharm Bull 1988; 36: 1095–1103
- Onyuksel H, Ramakrishanan S, Chai HB, Pezzuto JM. A mixed micellar formulation suitable for the parentheral administration of taxol. Pharm Res 1994; 11: 206–212
- Panyam J, Dali MM, Sahoo SK, Ma W, Chakravarthi SS, Amidon GL, Levy RJ, Labhasetwar V. Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles. J Control Rel 2003; 92: 173–187
- Perez MH, Zinutti C, Lamprecht A, Ubrich N, Astier A, Hoffman M, Bodmeier R, Maincent P. The preparation and evaluation of poly(ε-caprolactone) microparticles containing both a lipophilic and hydrophilic drug. J Control Rel 2000; 65: 429–438
- Perez-Rodriguez C, Montano N, Gonzales K, Griebenow K. Stabilization of α-chymotrypsin at the CH2Cl2/water interface and upon water-in-oil-in-water encapsulation in PLGA microspheres. J Control Rel 2003; 89: 71–85
- Quiglia F, De Rosa G, Granata E, Ungaro F, Fattal E, La Rotonda MI. Feeding liquid, non-ionic surfactant and cyclodextrin affect the properties of insulin-loaded poly(lactide-co-glycolide) microspheres prepared by spray-drying. J Control Rel 2003; 86: 267–278
- Ruan G, Feng S-S. Preparation and characterisation of poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel. Biomaterials 2003; 24: 5037–5044
- Schreier H. The new frontier: Gene and oligonucleotide therapy. Pharm Acta Helv 1994; 63: 145–159
- Sharma A, Balasubramanian BV, Straubinger RM. Pharmaceutical and physical properties of paclitaxel (Taxol) complexes with cyclodextrins. J Pharm Sci 1995; 10: 1223–1230
- Sharma A, Straubinger RM. Novel taxol formulations: Preparation and characterisation of taxol-containing liposomes. Pharm Res 1994; 6: 889–896
- Sinha VR, Bansal K, Kaushik R, Kumria R, Trehan A. Poly-ε-caprolactone microspheres and nanospheres: An overview. Int J Pharm 2004; 278: 1–23
- Song CX, Labhasetwar V, Murphy H, Qu X, Humphrey WR, Shebuski RJ, Levy RJ. Formulation and characterisation of biodegradable nanoparticles for intravascular local drug delivery. J Control Rel 1997; 43: 197–212
- Thompson CJ, Hansford D, Higgins S, Hutcheon G, Rostron C, Munday DL. Enzymatic synthesis and evaluation of new novel ω-pentadecalactone polymers for the production of biodegradable microspheres. J Microencapsulation 2006; 23: 213–226
- Thompson CJ, Hansford D, Higgins S, Rostron C, Hutcheon G, Munday DL. Evaluation of ibuprofen-loaded microspheres prepared from novel copolyesters. Int J Pharm 2007; 329: 53–61
- Vaquette C, Fawzi-Grancher S, Lavalle P, Frochot C, Viriot M-L, Muller S, Wang X. In vitro biocompatibility of different polyester membranes. Bio-Med Mater Eng 2006; 16: S131–S136
- Watts PJ, Davis MC, Melia CD. Microencapsulation using emulsification/solvent evaporation: An overview of techniques and applications. Crit Rev Ther Drug Carrier Syst 1990; 7: 235–259
- Zhang JX, Zhu KJ. An improvement of double emulsion technique for preparing bovine serum albumin-loaded PLGA microspheres. J Microencapsulation 2004; 21: 775–785